Bull
$100.54
Scenario price
$85.980
+1.083 (+1.26%)At close
U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 795 outpatient physical therapy clinics in 45 states. Its reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. The Physical Therapy Operations segment consists of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. The IIP segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers.
US Physical Therapy Inc is a good buy right now, with a current price of $84.67 and a strong RSI of 60.69, indicating bullish momentum. The company reported a revenue increase of 8.5% year-over-year in Q2 2026, reaching $214.06 million, which beat market expectations. However, the main risk is the earnings miss, with a reported EPS of $0.25, falling short of expectations by $0.53, which could affect investor confidence.
JPMorgan
$95
2026-09-11
JPMorgan
2026-09-11
Price Target
$95
Barrington
$98
2026-08-10
Barrington
2026-08-10
Price Target
$98
Barrington
$90
2026-05-13
Barrington
2026-05-13
Price Target
$90
Citizens
$98
2026-05-08
Citizens
2026-05-08
Price Target
$98
Jefferies
$102
2026-03-09
Jefferies
2026-03-09
Price Target
$102
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

U.S. Physical Therapy Appoints New Board Member

U.S. Physical Therapy CEO Presents at Midwest Ideas Conference

U.S. Physical Therapy Appoints New CFO

USPH (USPH) Q2 2026 Earnings Call Transcript

U.S. Physical Therapy Reports Q2 Earnings Miss with Revenue Beat
U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 795 outpatient physical therapy clinics in 45 states. Its reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. The Physical Therapy Operations segment consists of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. The IIP segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).
US Physical Therapy Inc is a good buy right now, with a current price of $84.67 and a strong RSI of 60.69, indicating bullish momentum. The company reported a revenue increase of 8.5% year-over-year in Q2 2026, reaching $214.06 million, which beat market expectations. However, the main risk is the earnings miss, with a reported EPS of $0.25, falling short of expectations by $0.53, which could affect investor confidence.
7 analysts cover USPH: 2 rate it Buy, 5 Hold and 0 Sell. The average price target is 101.50.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.